Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsumasa Komori

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Clinical and Molecular Hepatology|December 9, 2020
Recent updates on the management of autoimmune hepatitisAtsumasa Komori
Clinical Calcium|October 28, 2015
[Clinical guidelines for bone disease in primary biliary cirrhosis]Hiromi Ishibashi, Atsumasa Komori
Clinical and Molecular Hepatology|November 11, 2024
Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatmentAtsumasa Komori, Yuki Kugiyama
Seminars in Liver Disease|May 24, 2007
Guidelines for therapy of autoimmune liver diseaseHiromi Ishibashi, Atsumasa Komori, Shinji Shimoda, et al.
Anticancer Research|June 29, 2026
Complementary Prognostic Value of ALBI Grade and Child-Pugh Classification in HCC Treated With SBRTDaisuke Nakamura, Yasuhide Motoyoshi, Shinya Nagaoka, et al.
Seminars in Immunopathology|May 27, 2009
Liver architecture, cell function, and diseaseHiromi Ishibashi, Minoru Nakamura, Atsumasa Komori, et al.
Journal of Cancer Research and Clinical Oncology|April 25, 2023
Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2AHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Journal of Nutritional Science|January 16, 2026
The predictive factors of hypozincemia in patients with chronic liver diseaseShoji Ando, Atsumasa Komori, Hiroshi Yatsuhashi, et al.
Molecular Immunology|January 18, 2006
Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cellsAtsumasa Komori, Zhenming Xu, Xiaoping Wu, et al.
Clinical Journal of Gastroenterology|June 28, 2018
Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis CNobuyuki Yamashita, Hironori Tanimoto, Shinji Shimoda, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Clinical and Molecular Hepatology|December 9, 2020
Recent updates on the management of autoimmune hepatitisAtsumasa Komori
Clinical Calcium|October 28, 2015
[Clinical guidelines for bone disease in primary biliary cirrhosis]Hiromi Ishibashi, Atsumasa Komori
Clinical and Molecular Hepatology|November 11, 2024
Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatmentAtsumasa Komori, Yuki Kugiyama
Seminars in Liver Disease|May 24, 2007
Guidelines for therapy of autoimmune liver diseaseHiromi Ishibashi, Atsumasa Komori, Shinji Shimoda, et al.
Anticancer Research|June 29, 2026
Complementary Prognostic Value of ALBI Grade and Child-Pugh Classification in HCC Treated With SBRTDaisuke Nakamura, Yasuhide Motoyoshi, Shinya Nagaoka, et al.
Seminars in Immunopathology|May 27, 2009
Liver architecture, cell function, and diseaseHiromi Ishibashi, Minoru Nakamura, Atsumasa Komori, et al.
Journal of Cancer Research and Clinical Oncology|April 25, 2023
Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2AHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Journal of Nutritional Science|January 16, 2026
The predictive factors of hypozincemia in patients with chronic liver diseaseShoji Ando, Atsumasa Komori, Hiroshi Yatsuhashi, et al.
Molecular Immunology|January 18, 2006
Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cellsAtsumasa Komori, Zhenming Xu, Xiaoping Wu, et al.
Clinical Journal of Gastroenterology|June 28, 2018
Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis CNobuyuki Yamashita, Hironori Tanimoto, Shinji Shimoda, et al.
Pageof 12